Inventor · disambiguated record
Shixiang Jia
Also filed as: JIA SHIXIANG
6 granted patents·7 pending applications·36 citations·filing 2019–2024
77Inventor score
Top patents by PatentIndex Score
13 records- 0196US11694428B1Method for detecting Ophiocephalus argus cantor under intra-class occulusion based on cross-scale layered feature fusionUNIV LUDONG·Filed 2023·Granted Jul 4, 2023·13 cites·10 claims
- 0295US11790640B1Method for detecting densely occluded fish based on YOLOv5 networkUNIV LUDONG·Filed 2023·Granted Oct 17, 2023·22 cites·6 claims
- 0384US12466886B2Method of treatment using a bispecific antibody binding bcma and CD3SHANDONG NEW TIME PHARMACEUTICAL CO LTD·Filed 2024·Granted Nov 11, 2025·0 cites·1 claims
- 0479US12030939B2Bispecific antibody binding BCMA and CD3SHANDONG NEW TIME PHARMACEUTICAL CO LTD·Filed 2019·Granted Jul 9, 2024·1 cites·15 claims
- 0570US2022002431A1Bispecific antibody binding to cd20 and cd3 and uses thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 0670US2023073411A1Homodimer-type bispecific antibody against her2 and cd3 and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 0769US2024254187A1Dual-function protein for lipid and blood glucose regulationAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2024·Application pending·0 cites
- 0868US2022002407A1Homodimer-type bispecific antibody targeting cd19 and cd3, and preparation method therefor and application thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 0966US2021371526A1Homodimeric bispecific antibody, preparation method therefor and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
- 1062US11981718B2Dual-function protein for lipid and blood glucose regulationAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2020·Granted May 14, 2024·0 cites·8 claims
- 1152US12039733B2Method for identifying individuals of oplegnathus punctatus based on convolutional neural networkUNIV LUDONG·Filed 2021·Granted Jul 16, 2024·0 cites·4 claims
- 1250US2023134182A1Method for efficiently separating and purifying recombinant human coagulate factor viii fc fusion proteinAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2021·Application pending·0 cites
- 1346US2022033476A1Fusion protein of mutated single-chain human coagulation factor viii, preparation method therefor, and use thereofAMPSOURCE BIOPHARMA SHANGHAI INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shixiang Jia files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →